308 related articles for article (PubMed ID: 15201227)
1. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
[TBL] [Abstract][Full Text] [Related]
2. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Paul M; Ben-Dor I; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2004 Oct; (4):CD003992. PubMed ID: 15495074
[TBL] [Abstract][Full Text] [Related]
3. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients.
Vidal L; Ben Dor I; Paul M; Eliakim-Raz N; Pokroy E; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003992. PubMed ID: 24105485
[TBL] [Abstract][Full Text] [Related]
4. Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients.
Paul M; Borok S; Fraser A; Vidal L; Cohen M; Leibovici L
Cochrane Database Syst Rev; 2005 Jul; (3):CD003914. PubMed ID: 16034915
[TBL] [Abstract][Full Text] [Related]
5. Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Paul M; Dickstein Y; Borok S; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; (1):CD003914. PubMed ID: 24425445
[TBL] [Abstract][Full Text] [Related]
6. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
[TBL] [Abstract][Full Text] [Related]
7. Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer.
Beyar-Katz O; Dickstein Y; Borok S; Vidal L; Leibovici L; Paul M
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003914. PubMed ID: 28577308
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; van de Wetering M; Kremer L; Leibovici L
Cochrane Database Syst Rev; 2005 Oct; (4):CD004386. PubMed ID: 16235360
[TBL] [Abstract][Full Text] [Related]
9. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2003; (3):CD003038. PubMed ID: 12917941
[TBL] [Abstract][Full Text] [Related]
10. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003038. PubMed ID: 23813455
[TBL] [Abstract][Full Text] [Related]
11. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
Vedi A; Cohn R
J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
[TBL] [Abstract][Full Text] [Related]
12. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Paul M; Yahav D; Fraser A; Leibovici L
J Antimicrob Chemother; 2006 Feb; 57(2):176-89. PubMed ID: 16344285
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; Vidal L; Lawrie TA; van de Wetering MD; Kremer LC; Leibovici L
Cochrane Database Syst Rev; 2012 Jan; 1(1):CD004386. PubMed ID: 22258955
[TBL] [Abstract][Full Text] [Related]
14. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Paul M; Borok S; Fraser A; Vidal L; Leibovici L
J Antimicrob Chemother; 2005 Apr; 55(4):436-44. PubMed ID: 15722392
[TBL] [Abstract][Full Text] [Related]
15. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
[TBL] [Abstract][Full Text] [Related]
16. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates for breast cancer.
Pavlakis N; Stockler M
Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
[TBL] [Abstract][Full Text] [Related]
18. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
Viscoli C; Bruzzi P; Glauser M
Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials.
Vidal L; Gafter-Gvili A; Borok S; Fraser A; Leibovici L; Paul M
J Antimicrob Chemother; 2007 Aug; 60(2):247-57. PubMed ID: 17562680
[TBL] [Abstract][Full Text] [Related]
20. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer.
Rubenstein EB; Rolston K; Benjamin RS; Loewy J; Escalante C; Manzullo E; Hughes P; Moreland B; Fender A; Kennedy K
Cancer; 1993 Jun; 71(11):3640-6. PubMed ID: 8490912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
